Myocardial trauma and damage were induced by two doses of isoproterenol 40 mg·kg-1 in rats. Isoproterenol injections alone caused the expected cardiotoxicity. Two doses of alprazolam 0.5 mg·kg-1 decreased the severity of electrocardiographic changes after isoproterenol injection and the amount of myocardial tissue damage. The frequency of ischaemic ST-T changes, flat or inverted T waves, Q wave appearance. and heart block was significantly reduced in the alprazolam group. The alprazolam treated group had a significantly smaller proportion of infarcted tissue in the ventricular section (2.3%) and in the apical sections (1.8%) than the vehicle injected rats (6.5% and 14.7% respectively). There was no difference in wet heart weight or in heart rate between the alprazolam group and the control group. These results show that alprazolam has a cardioprotective effect in rats treated with cardiac damaging doses of isoproterenol. 
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Anxiety may precipitate or exacerbate cardiac trauma or damage. 1 2 Therefore, anxiolytics are often included in the prevention or treatment of cardiac infarction. 3 The extent of the protective effects of the anxiolytics and their exact mechanisms of actions are unknown at present. However, increased concentrations of adrenaline in the anxious patient may contribute to cardiac problems. 3 Recently.
alprazolam has been shown not only to be an effective anxiolytic but also significantly to reduce stress induced concentrations of plasma catecholamines in rats4 and humans, 5 to decrease ventricular arrhthmias in dogs undergoing coronary artery ligation, and to reduce angina in combination with propranolol. Severity score was calculated by multiplying the universal grade of I (ischaemic ST-T changes), 2 (flat or inverted T waves), 3 (Q wave). or 4 (heart block) by the number of time periods in which change is noted.
tracing was obtained before the animals were killed. Hearts were removed, rinsed gently in saline, blotted dry, and weighed. The hearts were then sliced into atrial, ventricular, and apical sections in preparation for TIC staining. After staining and formalin fixation, the heart sections were further sliced and examined for evidence of infarction. Areas of infarct were excised and weighed on a Mettler balance to determine the proportion of infarcted tissue in the apical, atrial, and ventricular sections. The total proportion of cardiac tissue affected was also determined. The severity of ECG changes was graded on a severity scale of 1-4 (table 1). A severity score consisting of ischaemic ST-T changes (score 1), flat or inverted T waves (score 2), Q wave appearance (score 3), and heart block (score 4) was computed for each animal at each injection time by multiplying the severity grade (1-4) by the number of time periods in which these changes were noted.
Statistical analysis of the data was performed using a one way ANOV A, a two way ANOV A with repeated measures, and unpaired t tests as appropriate.
Results
After isoproterenol injection, the heart rate increased rapidly and appreciably from about 340 to 500 beats·min-1 and remained increased for about 6 h. The heart rate then decreased and reached about 380 beats·min-1 before the second injection. Again an injection of isoproterenol increased heart rate quickly to 580 beats·min-1 and the rate remained increased for 6 h but decreased to 340 beats·min-1 24 h later. No significant difference was noted in heart rate between the vehicle and the alprazolam treated group after any injection of isoproterenol or before killing of the animals.
There was no significant difference between the control group and the alprazolam treated group in the number of ectopic beats occurring per minute after any injection time (table 1) . There was no significant difference between the alprazolam group and the control group in severity score after the first isoproterenol injection on day I. However, after the second isoproterenol injection on day 2, the alprazolam group showed fewer ECG changes and had a significantly (p<0.05) lower severity score than did the control group.
There was no significant difference between the wet heart weights of the control and the alprazolam groups (table 2). There was no significant difference in proportion of atrial tissue infarcted between the control group and the alprazolam group. However, the alprazolam group had a significantly smaller proportion of infarcted tissue in the ventricular sections (p<0.05) and apical sections (p<0.001) and a smaller total proportion of tissue affected (p<0.025) than the control group.
Discussion

Isoproterenol
(or a degradation product of isoproterenol) produced a pronounced increase in heart rate which far outlasted the half life of isoproterenol and caused the expected cardiac toxicity in our control group such as ECG abnormalities and myocardial necrosis. 8-JO The group treated with isoproterenol and alprazolam showed significantly less cardiotoxicity. There was a substantial decrease in the severity of ECG changes and of the proportion of infarcted tissue.
It is of interest to speculate how alprazolam reduced 
